Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Technology Vent Cap Tst LSE:OXT London Ordinary Share GB0006640204 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 35.00p 30.00p 40.00p 35.00p 35.00p 35.00p 212.00 05:00:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 0.0 0.1 1.5 23.3 1.90

Oxford Technology Vent Cap (OXT) Latest News

More Oxford Technology Vent Cap News
Oxford Technology Vent Cap Takeover Rumours

Oxford Technology Vent Cap (OXT) Share Charts

1 Year Oxford Technology Vent Cap Chart

1 Year Oxford Technology Vent Cap Chart

1 Month Oxford Technology Vent Cap Chart

1 Month Oxford Technology Vent Cap Chart

Intraday Oxford Technology Vent Cap Chart

Intraday Oxford Technology Vent Cap Chart

Oxford Technology Vent Cap (OXT) Discussions and Chat

Oxford Technology Vent Cap Forums and Chat

Date Time Title Posts
04/11/201416:08Oxford Technology VCT with Charts & News40.00
19/8/200513:35Oxford Technology3.00

Add a New Thread

Oxford Technology Vent Cap (OXT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2017-03-23 11:00:5631.7321267.27O
View all Oxford Technology Vent Cap trades in real-time

Oxford Technology Vent Cap (OXT) Top Chat Posts

DateSubject
23/3/2017
08:20
Oxford Technology Vent Cap Daily Update: Oxford Technology Vent Cap Tst is listed in the General Financial sector of the London Stock Exchange with ticker OXT. The last closing price for Oxford Technology Vent Cap was 35p.
Oxford Technology Vent Cap Tst has a 4 week average price of 35p and a 12 week average price of 35.61p.
The 1 year high share price is 42.50p while the 1 year low share price is currently 35p.
There are currently 5,431,655 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Oxford Technology Vent Cap Tst is £1,901,079.25.
27/1/2014
12:57
127tolmers: SCANCELL COULD BE THE NEXT BIG BENEFICIARY OF THE SPATE OF LICENSING DEALS ....... Matthew Goodman in this week's Sunday Times suggests Scancell could be the next big beneficiary of the spate of licensing deals currently being struck in the super hot area of Cancer Immunotherapy: "There are likely to be further deals struck as the pharma giants strive to boost their exposure to this rapidly expanding market. Scancell, an AIM-listed company that is developing melanoma vaccines, is set to begin a search for a bigger partner to help fund late-stage trials of its treatments after publishing encouraging data last month. "We are looking at 2014 as the year we consummate a relationship or a deal to take this forward," said Richard Goodfellow, Scancell's joint chief executive. Most drug companies are also looking into how different immunotherapies could work in tandem with existing cancer treatments." Is this the trigger for the OXT price reversal?
Oxford Technology Vent Cap share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20170324 04:19:44